Antithrombotic therapy in patients with combined coronary heart disease and atrial fibrillation.

Thompson, Peter L; Morton, Allison C

Thompson, Peter L; Morton, Allison C.

Affiliation

Thompson PL; Heart Research Institute, Sir Charles Gairdner Hospital and University of Western Australia, Perth, Australia - peterlthompson@bigpond.com.

Panminerva Med ; 58(1): 23-33, 2016 Mar.

Article in En | MEDLINE | ID: mdl-26658287

Subject(s)

Atrial Fibrillation/drug therapy; Coronary Disease/drug therapy; Coronary Thrombosis/prevention & control; Fibrinolytic Agents/administration & dosage; Platelet Aggregation Inhibitors/therapeutic use; Purinergic P2Y Receptor Antagonists/therapeutic use; Stroke/prevention & control; Administration, Oral; Atrial Fibrillation/complications; Atrial Fibrillation/diagnosis; Coronary Disease/complications; Coronary Disease/diagnosis; Coronary Thrombosis/diagnosis; Coronary Thrombosis/etiology; Fibrinolytic Agents/adverse effects; Hemorrhage/chemically induced; Humans; Platelet Aggregation Inhibitors/adverse effects; Polypharmacy; Purinergic P2Y Receptor Antagonists/adverse effects; Risk Factors; Stroke/diagnosis; Stroke/etiology; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Coronary Thrombosis / Platelet Aggregation Inhibitors / Coronary Disease / Stroke / Purinergic P2Y Receptor Antagonists / Fibrinolytic Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Panminerva Med Year: 2016 Document type: Article Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links